MedTrace Logo

Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis

NCT01149525 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2026-05-12

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy of L-carnitine versus placebo in the treatment of fatigue in multiple sclerosis patients. This study will randomize 60 patients in a cross-over design. This study is sponsored by academic French health institutions.

Conditions

Interventions

DRUG

L-Carnitine

2g oral solution , twice per day (morning/evening), during 3 months

DRUG

Placebo

oral solution, twice per day (morning/evening), during 3 months

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Jean-Christophe OUALLET, MD-PhD · University Hospital Bordeaux, France

  • Geneviève CHENE, MD-PhD · USMR (University Hospital, Bordeaux)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-03-31
Completion
2013-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01149525 on ClinicalTrials.gov